My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 154

    1.

    Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?

    Pérez-García J, Cortés J.

    Breast Cancer Res. 2012 Jan 31;14(1):104. [Epub ahead of print]

    PMID:
    22297134
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system.

    Sun Y, Rowehl LM, Huang L, Mackenzie GG, Vrankova K, Komninou D, Rigas B.

    Breast Cancer Res. 2012 Jan 31;14(1):R20. [Epub ahead of print]

    PMID:
    22293394
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women.

    Chay WY, Ong WS, Tan PH, Jie Leo NQ, Ho GH, Wong CS, Chia KS, Chow KY, Tan M Sr, Ang P Sr.

    Breast Cancer Res. 2012 Jan 30;14(1):R19. [Epub ahead of print]

    PMID:
    22289271
    [PubMed - as supplied by publisher]

    Related citations

    4.

    The dynamic yin-yang interaction of CXCR4 and CXCR7 in breast cancer metastasis.

    Hawkins OE, Richmond A.

    Breast Cancer Res. 2012 Jan 26;14(1):103. [Epub ahead of print]

    PMID:
    22293321
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Do fatty breasts increase or decrease breast cancer risk?

    Shepherd JA, Kerlikowske K.

    Breast Cancer Res. 2012 Jan 25;14(1):102. [Epub ahead of print]

    PMID:
    22277587
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.

    Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H, Shen H.

    Breast Cancer Res. 2012 Jan 23;14(1):R17. [Epub ahead of print]

    PMID:
    22269215
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.

    Kasimir-Bauer S, Hoffmann O, Wallwiener D, Kimmig R, Fehm T.

    Breast Cancer Res. 2012 Jan 20;14(1):R15. [Epub ahead of print]

    PMID:
    22264265
    [PubMed - as supplied by publisher]

    Related citations

    8.

    MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.

    Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH.

    Breast Cancer Res. 2012 Jan 18;14(1):R14. [Epub ahead of print]

    PMID:
    22251626
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.

    Bundred NJ, Kenemans P, Yip CH, Beckmann MW, Foidart JM, Sismondi P, Schoultz BV, Vassilopoulou-Sellin R, Galta RE, Lieshout EV, Mol-Arts M, Planellas J, Kubista E.

    Breast Cancer Res. 2012 Jan 17;14(1):R13. [Epub ahead of print]

    PMID:
    22251615
    [PubMed - as supplied by publisher]

    Related citations

    10.

    MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.

    Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M.

    Breast Cancer Res. 2012 Jan 17;14(1):R12. [Epub ahead of print]

    PMID:
    22251451
    [PubMed - as supplied by publisher]

    Related citations

    11.

    Molecular profiling of patient-derived breast cancer xenografts.

    Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E.

    Breast Cancer Res. 2012 Jan 16;14(1):R11. [Epub ahead of print]

    PMID:
    22247967
    [PubMed - as supplied by publisher]

    Related citations

    12.

    Steps solidifying a role for SEPT9 in breast cancer suggest that greater strides are needed.

    Stanbery L, Petty EM.

    Breast Cancer Res. 2012 Jan 9;14:101. [Epub ahead of print]

    PMID:
    22236777
    [PubMed - as supplied by publisher]

    Related citations

    13.

    Trends in incidence and detection of advanced breast cancer at biennial screening mammography in The Netherlands: a population based study.

    Nederend J, Duijm LE, Voogd AC, Groenewoud JH, Jansen FH, Louwman MW.

    Breast Cancer Res. 2012 Jan 9;14(1):R10. [Epub ahead of print]

    PMID:
    22230363
    [PubMed - as supplied by publisher]

    Related citations

    14.

    Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.

    Schwab LP, Peacock DL, Majumdar D, Ingels JF, Jensen LC, Smith KD, Cushing RC, Seagroves TN.

    Breast Cancer Res. 2012 Jan 7;14(1):R6. [Epub ahead of print]

    PMID:
    22225988
    [PubMed - as supplied by publisher]

    Related citations

    15.

    Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study.

    Beiki O, Hall P, Ekbom A, Moradi T.

    Breast Cancer Res. 2012 Jan 6;14(1):R5. [Epub ahead of print]

    PMID:
    22225950
    [PubMed - as supplied by publisher]

    Related citations

    16.

    Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer.

    Aleskandarany MA, Green AR, Benhasouna AA, Barros FF, Neal K, Reis-Filho JS, Ellis IO, Rakha EA.

    Breast Cancer Res. 2012 Jan 6;14(1):R3. [Epub ahead of print]

    PMID:
    22225836
    [PubMed - as supplied by publisher]

    Related citations

    17.

    Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors.

    Thompson HJ, Sedlacek SM, Paul D, Wolfe P, McGinley JN, Playdon MC, Daeninck EA, Bartels SN, Wisthoff MR.

    Breast Cancer Res. 2012 Jan 6;14(1):R1. [Epub ahead of print]

    PMID:
    22225711
    [PubMed - as supplied by publisher]

    Related citations

    18.

    Long-term prognosis of breast cancer detected by mammography screening or other methods.

    Lehtimäki T, Lundin M, Linder N, Sihto H, Holli K, Turpeenniemi-Hujanen T, Kataja V, Isola J, Joensuu H, Lundin J.

    Breast Cancer Res. 2011;13(6):R134. Epub 2011 Dec 28.

    PMID:
    22204661
    [PubMed - in process]
    Free PMC Article

    Related citations

    19.

    Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles.

    Jacot W, Lopez-Crapez E, Thezenas S, Senal R, Fina F, Bibeau F, Romieu G, Lamy PJ.

    Breast Cancer Res. 2011;13(6):R133. Epub 2011 Dec 22.

    PMID:
    22192147
    [PubMed - in process]
    Free PMC Article

    Related citations

    20.

    A genome-wide linkage study of mammographic density, a risk factor for breast cancer.

    Greenwood CM, Paterson AD, Linton L, Andrulis IL, Apicella C, Dimitromanolakis A, Kriukov V, Martin LJ, Salleh A, Samiltchuk E, Parekh RV, Southey MC, John EM, Hopper JL, Boyd NF, Rommens JM.

    Breast Cancer Res. 2011;13(6):R132. Epub 2011 Dec 21.

    PMID:
    22188651
    [PubMed - in process]
    Free PMC Article

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk